A group of wealthy countries, representing 13 percent of the world's population, have purchased more than 50 percent of future corona virus vaccines. This has been claimed in an Oxfam report. Based on data collected by analytics company Airfinity, the non-governmental organization has analyzed the deals between the five vaccine-producing companies, pharmaceuticals and buyer countries currently undergoing final testing.
After this report, Robert Silverman of Oxfam America said, "Access to the life-saving vaccine should not depend on where you live or how much money you have." He said, "The development and approval of a safe and effective vaccine is important, but equally important is to ensure that vaccines are available to everyone and affordable because Kovid-19 is not just one place but everywhere."
The five vaccines analyzed include AstraZeneca, Gamalaya / Sputnik, Modern, Pfizer and Synovac vaccines.